Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100045/S087

CardioMEMS HF System (Merlin.net PCN HF Portal (Model MN6000) and CardioMEMS Backend Web Application (Model CM4000))

ABBOTT MEDICAL · Decision date Nov 10, 2025

FDA DECISIONP100045/S087

What did the FDA approve?

FDA records P100045/S087 as a supplement to PMA P100045, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Nov 10, 2025.

FDA approval order statement

Approval for a software maintenance release (SMR 1.1) containing software modifications to the CardioMEMS HF System.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Nov 10, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P100045/S087
Regulatory pathway
PMA supplement
Product code
MOM
Decision code
APPR
Decision date
Nov 10, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, hemodynamic, implantable.

Product code
MOM
FDA device class
3

For the original device and its historical approval scope, see PMA P100045. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P100045 · Original PMA

    CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM

  2. P100045/S087 received

    Application receipt date recorded by FDA.

  3. P100045/S085 · Related supplement

    CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM

  4. P100045/S087 · FDA decision

    Real-Time Process

  5. P100045/S086 · Related supplement

    Next Gen Patient System CM1200 CardioMEMS HERO Device

  6. P100045/S092 · Related supplement

    CardioMEMS PA Sensor and Delivery System (CM2000); CardioMEMS HF System

  7. P100045/S091 · Related supplement

    CardioMEMS HF System; Merlin.net PCN HF Portal (Model MN6000); CardioMEMS Backend Web Application (Model CM4000); HF Clo

  8. P100045/S093 · Related supplement

    CardioMEMS PA Sensor and Delivery System

Timeline entries are records held by MedtechLedger for P100045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100045

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalMay 28, 2014FDA
ABBOTT MEDICALPMA supplementJul 28, 2025FDA
ABBOTT MEDICALPMA supplementSep 10, 2025FDA
ABBOTT MEDICALPMA supplementSep 17, 2025FDA
ABBOTT MEDICALPMA supplementSep 24, 2025FDA
ABBOTT MEDICALPMA supplementJan 9, 2026FDA
ABBOTT MEDICALPMA supplementFeb 27, 2026FDA
ABBOTT MEDICALPMA supplementMar 25, 2026FDA
ABBOTT MEDICALPMA supplementMay 13, 2026FDA
ABBOTT MEDICALPMA supplementJun 1, 2026FDA
ABBOTT MEDICALPMA supplementSep 11, 2026FDA
ABBOTT MEDICALPMA supplementSep 30, 2026FDA
ABBOTT MEDICALPMA supplementSep 30, 2026FDA

Explore the linked device profile

Other records with product code MOM

Product / regulatory recordCompanyPathwayDecision dateSource
Endotronix, Inc.PMA supplementOct 29, 2026FDA
Endotronix, Inc.PMA supplementOct 20, 2026FDA
Endotronix, Inc.PMA supplementOct 16, 2026FDA
Endotronix, Inc.PMA supplementOct 14, 2026FDA
Endotronix, Inc.PMA supplementSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
387 Nerem St. NW, Suite #500, Atlanta, GA, 30313

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records